The L-type calcium channel blocker nifedipine impairs extinction, but not reduced contingency effects, in mice

  1. Christopher K. Cain1,
  2. Bill P. Godsil2,
  3. Shekib Jami2, and
  4. Mark Barad2,3,4
  1. 1Interdepartmental Program in Neuroscience, 2Department of Psychiatry and Biobehavioral Sciences, and 3Neuropsychiatric Institute and Brain Research Institute, University of California Los Angeles, Los Angeles, California 90095-1761, USA

Abstract

We recently reported that fear extinction, a form of inhibitory learning, is selectively blocked by systemic administration of L-type voltage-gated calcium channel (LVGCC) antagonists, including nifedipine, in mice. We here replicate this finding and examine three reduced contingency effects after vehicle or nifedipine (40 mg/kg) administration. In the first experiment, contingency reduction was achieved by adding USs to the training protocol (degraded contingency), a phenomenon thought to be independent of behavioral inhibition. In the second experiment, contingency reduction was achieved by varying the percentage of CS-US pairing, a phenomenon thought to be weakly dependent on behavioral inhibition. In the third and fourth experiments, contingency reduction was achieved by adding CSs to the training protocol (partial reinforcement), a phenomenon thought to be completely dependent on behavioral inhibition. We found that none of these reduced contingency effects was impaired by nifedipine. In a final experiment, we found that extinction conducted 1 or 3 h post-acquisition, but not immediately, was LVGCC-dependent. Taken together, the results suggest that reduced contingency effects and extinction depend on different molecular mechanisms and that LVGCC dependence of behavioral inhibition develops with time after associative CS-US learning.

Footnotes

  • Article and publication are at http://www.learnmem.org/cgi/doi/10.1101/lm.88805.

    • Accepted April 7, 2005.
    • Received November 9, 2004.
| Table of Contents